These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6539202)

  • 1. Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine treatment of severe herpes zoster in cancer patients.
    Wildiers J; De Clercq E
    Eur J Cancer Clin Oncol; 1984 Apr; 20(4):471-6. PubMed ID: 6539202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral BVDU treatment of varicella and zoster in children with cancer.
    Benoit Y; Laureys G; Delbeke MJ; De Clercq E
    Eur J Pediatr; 1985 Jan; 143(3):198-202. PubMed ID: 3987714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [5-(2-bromovinyl)-2'-deoxyuridine therapy of herpes zoster diseases in patients with malignant primary diseases].
    Wutzler P; Wutke K; Bärwolff D; Reefschläger J
    Z Gesamte Inn Med; 1988 Dec; 43(23):677-80. PubMed ID: 2854331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.
    De Clercq E
    Biochem Pharmacol; 2004 Dec; 68(12):2301-15. PubMed ID: 15548377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.
    de Clercq E; Degreef H; Wildiers J; de Jonge G; Drochmans A; Descamps J; de Somer P
    Br Med J; 1980 Nov; 281(6249):1178. PubMed ID: 7427624
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral bromovinyldeoxyuridine therapy for herpes simplex and varicella-zoster virus infections in severely immunosuppressed patients: a preliminary clinical trial.
    Tricot G; De Clercq E; Boogaerts MA; Verwilghen RL
    J Med Virol; 1986 Jan; 18(1):11-20. PubMed ID: 3511181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    De Clercq E; Descamps J; Ogata M; Shigeta S
    Antimicrob Agents Chemother; 1982 Jan; 21(1):33-8. PubMed ID: 6282207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.
    de Clercq E; Zhang ZX; Sim IS
    Antimicrob Agents Chemother; 1982 Sep; 22(3):421-5. PubMed ID: 7137983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brivudin (bromovinyl deoxyuridine).
    Keam SJ; Chapman TM; Figgitt DP
    Drugs; 2004; 64(18):2091-7; discussion 2098-9. PubMed ID: 15341504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and topical treatment of experimental HSV-1 genital herpes with (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Sim IS
    J Antimicrob Chemother; 1984 Aug; 14 Suppl A():111-8. PubMed ID: 6541647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results of oral BVDU treatment of herpes zoster ophthalmicus.
    Maudgal PC; Dralands L; Lamberts L; De Clercq E; Descamps J; Missotten L
    Bull Soc Belge Ophtalmol; 1981; 193():49-56. PubMed ID: 6979370
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy of Herpes zoster infections.
    Hirsch MS
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):871-2. PubMed ID: 6540187
    [No Abstract]   [Full Text] [Related]  

  • 13. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
    De Clercq E
    Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
    Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of varicella-zoster virus infection--mechanism of action of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Shigeta S; Yokota T; De Clercq E
    Antiviral Res; 1985; Suppl 1():35-44. PubMed ID: 3002264
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
    Maudgal PC; De Clercq E; Missotten L
    Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromovinyldeoxyurdine treatment of outer retinal necrosis due to varicella-zoster virus: a case-report.
    Dullaert H; Maudgal PC; Leys A; Dralands L; Clercq E
    Bull Soc Belge Ophtalmol; 1996; 262():107-13. PubMed ID: 9339038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study.
    Wassilew SW; Wutzler P;
    Antiviral Res; 2003 Jun; 59(1):49-56. PubMed ID: 12834860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perineal muco-cutaneous herpes zoster treated with brivudin.
    Correia O; Pereira MA; Pereira T; Santos A
    J Dermatolog Treat; 2008; 19(4):255-6. PubMed ID: 18608718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of BVDU: An odyssey.
    De Clercq E
    Antivir Chem Chemother; 2023; 31():20402066231152971. PubMed ID: 36710501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.